| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.03 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |